Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriatic arthritis

C Salvarani1, I Olivieri, F Cantini

  • 1Servizio di Reumatologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.

Current Opinion in Rheumatology
|September 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro pharmacological modulation of NKG2D expression in immune cells from Behçet syndrome patients.

Clinical and experimental immunology·2026
Same author

Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years.

Ocular immunology and inflammation·2024
Same author

Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon.

Ocular immunology and inflammation·2023
Same author

Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis?

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2022
Same author

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis.

Reumatismo·2022
Same author

Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2D<sup>pos</sup> NK and NK T cells.

Clinical and experimental immunology·2020
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Psoriatic arthritis (PsA) diagnosis lacks definitive criteria, with current methods showing low sensitivity. Early recognition of PsA subsets and multidisciplinary treatment are crucial for effective patient management.

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Psoriatic arthritis (PsA) diagnosis and classification remain challenging due to limitations in current criteria.
  • Existing criteria, such as Moll and Wright's, exhibit low sensitivity in identifying the full spectrum of PsA.
  • Certain PsA presentations, like isolated peripheral enthesitis, may be underrecognized by standard diagnostic schemes.

Purpose of the Study:

  • To review current understanding of psoriatic arthritis (PsA) diagnosis, classification, and treatment.
  • To highlight the limitations of existing diagnostic criteria for PsA.
  • To discuss emerging research on PsA pathogenesis and therapeutic strategies.

Main Methods:

  • Review of recent population-based studies on PsA incidence, prevalence, and survival.

Related Experiment Videos

  • Analysis of diagnostic criteria sensitivity (Moll and Wright, European Spondyloarthropathy Study Group, Amor).
  • Examination of research on molecular markers (adhesion molecules, cytokines, chemokines) in PsA synovial fluid and membrane.

    • Main Results:

    • Current diagnostic criteria for PsA have limited sensitivity.
    • A subset of PsA patients with peripheral enthesitis may not be adequately identified by existing criteria.
    • Research is exploring molecular mechanisms and therapeutic targets in PsA.

    Conclusions:

    • PsA diagnosis requires improved criteria to capture its full spectrum.
    • A multidisciplinary approach involving rheumatologists and dermatologists is essential for optimal PsA management.
    • Combination therapies with methotrexate, sulfasalazine, and cyclosporine show promise as established treatments for PsA.